Development of High Throughput Screening Systems for Novel Agents Targeting Thyroid Epithelial Cancers
Part of the Surgical Grand Rounds Series - Jason Prescott, MD, describes the principles and potential translational value of high throughput drug screening and reviews current management of epithelial thyroid cancers, with emphasis on treatment refractory disease.
Related Presenters